Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy. Relation to Remodeling

Journal of the American College of Cardiology

Volumn 53, Issue 3, 2009, Pages 284-291

  Rudolph, Andre ^a   Abdel Aty, Hassan ^a   Bohl, Steffen ^a   Boyé, Philipp ^a   Zagrosek, Anja ^a   Dietz, Rainer ^a   Schulz Menger, Jeanette ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cardiac magnetic resonance imaging; cardiomyopathy; late gadolinium enhancement; left ventricular hypertrophy

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL MORPHOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; AORTIC VALVE STENOSIS; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GADOLINIUM; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VENTRICULAR REMODELING;

EID: 58149287871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.064     Document Type: Article

References (57)

1. Gradman A.H., and Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48 (2006) 326-341
2. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 23 (2005) S27-S33
3. Gosse P. Left ventricular hypertrophy-the problem and possible solutions. J Int Med Res 33 Suppl 1 (2005) 3A-11A
4. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
5. Richard P., Villard E., Charron P., and Isnard R. The genetic bases of cardiomyopathies. J Am Coll Cardiol 48 (2006) A79-A89
6. Carabello B.A. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease. J Heart Valve Dis 4 Suppl 2 (1995) S132-S138 discussion S138-9.
7. St. John Sutton M.G., Lie J.T., Anderson K.R., O'Brien P.C., and Frye R.L. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 44 (1980) 433-443
8. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
9. Fujiwara H., Tanaka M., Onodera T., and Kawai C. [Hypertrophic cardiomyopathy: mode of death and pathological findings]. J Cardiol Suppl 16 (1987) 3-8
10. Anderson K.R., Sutton M.G., and Lie J.T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128 (1979) 79-85
11. Fabre A., and Sheppard M.N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 92 (2006) 316-320
12. Emoto R., Yokota Y., Miki T., et al. [Prognosis of hypertrophic cardiomyopathy: echocardiographic and postmortem histopathologic study of 30 patients]. J Cardiol 18 (1988) 695-703
13. Brandenburg R.O. Cardiomyopathies and their role in sudden death. J Am Coll Cardiol 5 (1985) 185B-189B
14. Kawano H., Toda G., Nakamizo R., Koide Y., Seto S., and Yano K. Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy. Circ J 69 (2005) 1244-1248
15. Bellenger N.G., Davies L.C., Francis J.M., Coats A.J., and Pennell D.J. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2 (2000) 271-278
16. Moon J.C., and Prasad S.K. Cardiovascular magnetic resonance and the evaluation of heart failure. Curr Cardiol Rep 7 (2005) 39-44
17. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
18. Vasan R.S., Larson M.G., Levy D., Evans J.C., and Benjamin E.J. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 96 (1997) 1863-1873
19. Schulz-Menger J., Abdel-Aty H., Rudolph A., et al. Gender-specific differences in left ventricular remodeling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance. Eur J Heart Fail 10 (2008) 850-854
20. Friedrich M., Schulz-Menger J., and Dietz R. Magnetic resonance to assess the aortic valve area in aortic stenosis. J Am Coll Cardiol 43 (2004) 2148, author reply 2148-9.
21. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48 (2006) e1-e148
22. Mancia G., De Backer G., Dominiczak A., et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187
23. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
24. Schulz-Menger J., Abdel-Aty H., Busjahn A., et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 8 (2006) 741-746
25. Friedrich M.G., Schulz-Menger J., Poetsch T., Pilz B., Uhlich F., and Dietz R. Quantification of valvular aortic stenosis by magnetic resonance imaging. Am Heart J 144 (2002) 329-334
26. Kupfahl C., Honold M., Meinhardt G., et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart 90 (2004) 893-901
27. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
28. Vatner S.F. Reduced subendocardial myocardial perfusion as one mechanism for congestive heart failure. Am J Cardiol 62 (1988) 94E-98E
29. Hudlicka O., Brown M., and Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72 (1992) 369-417
30. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003) 984-991
31. Debl K., Djavidani B., Buchner S., et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 92 (2006) 1447-1451
32. Kupari M., Turto H., and Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?. Eur Heart J 26 (2005) 1790-1796
33. Martos R., Baugh J., Ledwidge M., et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115 (2007) 888-895
34. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84
35. Schillaci G., Pasqualini L., Verdecchia P., et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 39 (2002) 2005-2011
36. Moon J.C., Mogensen J., Elliott P.M., et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91 (2005) 1036-1040
37. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
38. Papavassiliu T., Schnabel P., Schroder M., and Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26 (2005) 2395
39. Nakanishi S., Nishiyama S., Nishimura S., Yamaguchi H., and Matsuya S. [Histological features of apical hypertrophic cardiomyopathy]. J Cardiogr Suppl (1985) 3-11
40. Autore C., Bernabo P., Barilla C.S., Bruzzi P., and Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45 (2005) 1076-1080
41. Elliott P.M., Gimeno J.R., Tome M.T., et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1933-1941
42. Maron B.J., Wolfson J.K., Epstein S.E., and Roberts W.C. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 545-557
43. Petersen S.E., Jerosch-Herold M., Hudsmith L.E., et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115 (2007) 2418-2425
44. Olivotto I., Cecchi F., Gistri R., et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1043-1048
45. Unverferth D.V., Baker P.B., Pearce L.I., Lautman J., and Roberts W.C. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 59 (1987) 932-936
46. Kuribayashi T., and Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70 (1992) 1333-1340
47. Moon J.C. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?]. Rev Esp Cardiol 60 (2007) 1-4
48. Shirani J., Pick R., Roberts W.C., and Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35 (2000) 36-44
49. Sengupta P.P., Korinek J., Belohlavek M., et al. Left ventricular structure and function: basic science for cardiac imaging. J Am Coll Cardiol 48 (2006) 1988-2001
50. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
51. Schwartzkopff B., Motz W., Vogt M., and Strauer B.E. Heart failure on the basis of hypertension. Circulation 87 (1993) IV66-IV72
52. Matsumura K., Fujii K., Oniki H., Oka M., and Iida M. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 19 (2006) 13-18
53. Shapiro L.M. Hypertrophic cardiomyopathy in the elderly. Br Heart J 63 (1990) 265-266
54. Kwong R.Y., Chan A.K., Brown K.A., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743
55. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
56. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
57. Reimer K.A., Lowe J.E., Rasmussen M.M., and Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794